Protein kinase A activity in platelets from patients with bipolar disorder

Journal of Affective Disorders

Volumn 76, Issue 1-3, 2003, Pages 249-253

  Tardito, Daniela ^a   Mori, Silvia ^a   Racagni, Giorgio ^a   Smeraldi, Enrico ^b   Zanardi, Raffaella ^b   Perez, Jorge ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bipolar disorder; cAMP signaling; PKA activity; Platelets

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0042009837     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00065-4     Document Type: Article

References (26)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A.S., Kandel E.R., Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 88:1997;615-626.
2. Adams M.R., Brandon E.P., Chartoff E.H., Idzerda R.L., Dorsa D.M., McKnight G.S. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;12157-12161.
3. Brandon E.P., Logue S.F., Adams M.R., Qi M., Sullivan S.P., Matsumoto A.M., Dorsa D.M., Wehner J.M., McKight G.S., Idzerda R.L. Defective motor behavior and neural gene expression in RIIb-protein kinase A mutant mice. J. Neurosci. 18:1998;3639-3649.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. DSM-IV, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. American Psychiatric Association.
6. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., Young T.L. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J. Neurochem. 73:1999;1121-1126.
7. Emamghoreishi M., Schlichter L., Li P.P., Parikh P., Sen J., Kamble A., Warsh J.J. High intracellular calcium concentration in transformed lymphoblasts from subjects with bipolar I disorder. Am. J. Psychiatry. 154:1997;976-982.
8. Fields A., Li P.P., Kish S.J., Warsh J.J. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J. Neurochem. 73:1999;1704-1710.
9. Goodwin F.K., Jamison K.R. Manic-depressive Illness. 1990;Oxford University Press, New York.
10. Hahn C.G., Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disorders. 2:1999;81-86.
11. Hyman S. Mental illness: genetically complex disorders of neural circuitry and neural communication. Neuron. 28:2000;321-323.
12. Jope R.S., Song L., Li P.P., Young L.T., Kish S.J., Pacheco M.A., Warsh J.J. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66:1996;2402-2409.
13. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry. 39:1982;879-883.
14. 3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants. Brain Res. 758:1997;223-228.
15. Manji H.K., Lenox R.H. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol. Psychiatry. 48:2000;518-530.
16. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338:1998;171-179.
17. McEwen B.S. Allostasis and allostatic load: implications for neuropharmacology. Neuropsychopharmacology. 22:2000;108-124.
18. Mori S., Tardito D., Dorigo A., Zanardi R., Smeraldi E., Racagni G., Perez J. Effects of lithium on cAMP-dependent protein kinase in rat brain. Neuropsychopharmacology. 19:1998;233-240.
19. Perera T., Lisanby S.H., Sackeim H.A. Protein kinase A in major depression: the link between hypothalamic-pituitary-adrenal axis hyperactivity and neurogenesis. CNS Spectrum. 6:2001;565-572.
20. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., Zanardi R. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch. Gen. Psychiatry. 56:1999;248-253.
21. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., Zanardi R. Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment. Bipolar Disorders. 2:2000;27-36.
22. Perez J., Tardito D., Racagni G., Smeraldi E., Zanardi R. Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol. Psychiatry. 6:2001;44-49.
23. Perez J., Tardito D. Implications of the cAMP signaling pathway in psychiatric disorders: a systematic review of the evidence. CNS Spectrum. 6:2001;294-305.
24. 3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 68:1997;297-304.
25. Shelton R.C., Manier D.H., Peterson C.S., Ellis T.C., Sulser F. Cyclic AMP-dependent protein kinase activity in subtypes of major depression and normal volunteers. Int. J. Neuropsychopharmacol. 2:1999;187-192.
26. Stewart R.J., Chen B., Dowlatshahi D., MacQueen G.M., Young L.T. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res. Bull. 55:2001;625-629.